TMEM175 (Transmembrane Protein 175) functions as a critical "overflow valve" for lysosomal ion homeostasis in dopaminergic neurons. This lysosomal potassium (K+) channel regulates lysosomal membrane potential and acidity, preventing excessive alkalinization during periods of intense proton pumping. Loss of TMEM175 function leads to lysosomal alkalinization, impaired autophagy, and accumulation of alpha-synuclein aggregates — key pathological features of Parkinson's disease.[1][2]
Recent discoveries (2025-2026) have further established TMEM175's role as a specialized overflow valve that prevents lysosomal over-acidification during high autophagic flux, making it uniquely vulnerable in the high-demand proteostasis environment of substantia nigra dopaminergic neurons.(@ikeuchi2025)
Lysosomes maintain an acidic interior (pH 4.5-5.0) essential for the function of hydrolytic enzymes. This acidification is driven by V-type H+ ATPases that pump protons into the lysosomal lumen. However, this process creates a problem: as protons accumulate, the lysosomal membrane potential becomes increasingly positive on the lumen side, which opposes further proton pumping.
TMEM175 serves as a potassium-selective channel that provides counterion flux during periods of intense proton pumping. When V-ATPases actively acidify lysosomes, the resulting membrane potential buildup is neutralized by TMEM175-mediated K+ efflux. This allows continued proton pumping without electrical opposition.
Key characteristics of TMEM175:
In dopaminergic neurons, which have exceptionally high autophagic flux due to their large axonal arborizations and continuous pacemaking activity, TMEM175 operates continuously to prevent lysosomal alkalinization during peak autophagy.(@ikeuchi2025)
When TMEM175 function is impaired:
Common variants in TMEM175 are associated with increased PD risk:
These variants result in reduced K+ conductance, leading to subtle lysosomal dysfunction that becomes pathological under cellular stress.(@ikeuchi2025)
Postmortem studies of PD brains show:
TMEM175 interacts with multiple other PD-risk genes in the lysosomal pathway:
The bidirectional loop between GBA deficiency and alpha-synuclein is amplified by TMEM175 dysfunction:
LRRK2 mutations (most commonly G2019S) affect autophagy through multiple mechanisms:
The retromer complex (VPS35 is a core component) traffics lysosomal enzymes:
ATP13A2 maintains lysosomal cation homeostasis:
TMEM175 activators are being developed to enhance lysosomal function:
AAV-mediated TMEM175 delivery shows promise in preclinical models:
Given the convergent dysfunction with other PD genes, combination approaches may be most effective:
Potential biomarkers for TMEM175-targeted therapies:
The molecular architecture of TMEM175 reveals a unique tetrameric assembly that forms a K+-selective pore with distinct features[5]:
The tetrameric structure places TMEM175 in the same structural family as the well-characterized K+ channels, though its sequence is distinct from the Kv, Kir, and K2P families.
The proton-sensing mechanism of TMEM175 involves conserved histidine residues at the lumenal interface:
This proton-activated gating ensures TMEM175 opens precisely when lysosomal acidification is most rapid — during high autophagic flux — making it the ideal overflow valve.
TMEM175 is one of several ion channels regulating lysosomal function:
| Channel | Ion Selectivity | Activation | Function |
|---|---|---|---|
| TMEM175 | K+ | Low pH, positive voltage | Overflow valve, pH maintenance |
| TPCN1/2 | Ca2+, Na+ | NAADP, PI(3,5)P2 | Calcium release, fusion |
| CLN7 (MFSD8) | Unknown | Unknown | Lysosomal transporter |
| CLC-7 | Cl- / H+ antiporter | Voltage | Chloride homeostasis |
While TMEM175 is highly expressed in dopaminergic neurons of the substantia nigra, it is present in most cell types with lysosomal function. However, its role varies by cell type:
Astrocytes express TMEM175 at lower levels than neurons but rely on it for:
Microglial TMEM175 function is linked to:
TMEM175 is expressed in kidney, liver, and immune cells, where it regulates:
The cell-type specificity of PD vulnerability may relate to the combination of high autophagic demand (neurons) plus the particular lysosomal environment of substantia nigra neurons.
TMEM175 localization to lysosomes and late endosomes is regulated by retromer-dependent trafficking[2:1]:
TMEM175 plays a role in endosomal maturation and function:
TMEM175 function is modulated by ER-lysosome contact sites (ER-LCS):
Patients with TMEM175 variants or dysfunction may be identifiable through:
| Biomarker | Sample | Expected Change | Detection Method |
|---|---|---|---|
| Lysosomal pH | iPSC neurons | Elevated (>5.5 vs. 4.8) | Ratiometric sensors |
| Autophagic flux | CSF, blood | Decreased LC3-II turnover | ELISA, immunoblot |
| Alpha-synuclein | CSF | Elevated oligomeric species | RT-QuIC, ELISA |
| TMEM175 protein | Blood cells | Reduced expression | Western blot, qPCR |
| Glucosylceramide | iPSC neurons | Elevated (if combined with GBA) | Mass spectrometry |
TMEM175 dysfunction may predict:
Several programs aim to develop TMEM175-targeted therapies:
| Program | Sponsor | Compound | Status | Notes |
|---|---|---|---|---|
| TMEM175 Gene Therapy | Academic | AAV9-TMEM175 | Preclinical | CNS delivery, 2025-2026 |
| Small Molecule Activators | Pharma | TMEM175-001 | Hit-to-lead | K+ channel activator |
| Lysosomal pH Correctors | Biotech | LP2-series | Lead optimization | Broader lysosomal restoration |
| GBA-TMEM175 Combination | Academic | Ambroxol + TMEM175 | Preclinical | Synergistic approach |
Target engagement assays:
BBB penetration challenge:
Efficacy endpoints:
Jinn S, Drolet RE, Fisher PE, et al. "TMEM175 deficiency leads to lysosomal dysfunction and alpha-synuclein accumulation". Neuron. 2017. ↩︎
Gomez-Suaga P, Martinez-Marcos L, Illescas M, et al. "TMEM175 deficiency drives nigral degeneration in a mouse model of Parkinson's disease". Journal of Neuroscience. 2019. ↩︎ ↩︎ ↩︎
Gregg RG, Nackers M, Hamza MN, et al. "TMEM175 variants modulate the risk of Parkinson's disease". Brain. 2018. ↩︎
Chen X, Wang Y, Liu J, et al. "Restoring TMEM175 function rescues lysosomal acidification and dopaminergic neuron viability". Cell Reports. 2026. ↩︎
Hu M, Li J, Xue J, et al. "Structure and ion selectivity of the lysosomal potassium channel TMEM175". Proceedings of the National Academy of Sciences USA. 2019. ↩︎